|
|
Volumn 2, Issue 2, 2005, Pages 74-75
|
|
Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?
|
|
Author keywords
Non Hodgkin's lymphoma; Rituximab; Survival; Transplantation
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
METHOTREXATE;
METHYLPREDNISOLONE;
MITOXANTRONE;
RITUXIMAB;
ANTINEOPLASTIC ACTIVITY;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
BACTEREMIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GRADING;
CANCER RELAPSE;
CANCER SURVIVAL;
CANDIDIASIS;
CLINICAL TRIAL;
COLITIS;
DRUG RESPONSE;
FEBRILE NEUTROPENIA;
FOLLOW UP;
HEART ARRHYTHMIA;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LENGTH OF STAY;
MAINTENANCE THERAPY;
MUCOSA INFLAMMATION;
MULTIVARIATE ANALYSIS;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SALVAGE THERAPY;
SHORT SURVEY;
STEM CELL MOBILIZATION;
SURVIVAL RATE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
WHOLE BODY RADIATION;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
FEMALE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SALVAGE THERAPY;
STEM CELL TRANSPLANTATION;
SURVIVAL ANALYSIS;
TRANSPLANTATION, AUTOLOGOUS;
TREATMENT OUTCOME;
|
|
EID: 20344393881
PISSN: 17434254
EISSN: None
Source Type: Journal
DOI: 10.1038/ncponc0078 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (5)
|
